Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Small Intestinal Bacterial Overgrowth (SIBO) |
📓
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome - An Update. Frontiers in psychiatry (Front Psychiatry ) Vol: 11 Issue Pages: 664 Pub: 2020 Epub: 2020 Jul 10 Authors Takakura W , Pimentel M , Html Article Publication |
| Small Intestinal Bacterial Overgrowth (SIBO) |
📓
Irritable Bowel Syndrome, Particularly the Constipation-Predominant Form, Involves an Increase in <i>Methanobrevibacter smithii</i>, Which Is Associated with Higher Methane Production. Gut and liver (Gut Liver ) Vol: 10 Issue 6 Pages: 932-938 Pub: 2016 Nov 15 Epub: Authors Ghoshal U , Shukla R , Srivastava D , Ghoshal UC , Html Article Publication |
| Small Intestinal Bacterial Overgrowth (SIBO) |
📓
Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. European journal of gastroenterology & hepatology (Eur J Gastroenterol Hepatol ) Vol: 26 Issue 7 Pages: 753-60 Pub: 2014 Jul Epub: Authors Ghoshal UC , Srivastava D , Ghoshal U , Misra A , Publication |
| Small Intestinal Bacterial Overgrowth (SIBO) |
📓
Fecal microbiota analysis of children with small intestinal bacterial overgrowth among residents of an urban slum in Brazil. Jornal de pediatria (J Pediatr (Rio J) ) Vol: 94 Issue 5 Pages: 483-490 Pub: 2018 Sep - Oct Epub: 2017 Oct 16 Authors Mello CS , Rodrigues MSDC , Filho HBA , Melli LCFL , Tahan S , Pignatari ACC , de Morais MB , Publication |
| Small Intestinal Bacterial Overgrowth (SIBO) |
📓
[Lactase deficiency in patients with postinfectious irritable bowel syndrome and the role of intestinal microflora in its development]. Eksperimental`naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology (Eksp Klin Gastroenterol ) Vol: Issue 5 Pages: 91-8 Pub: 2012 Epub: Authors Shcherbakova PL , Parfenov AI , Ruchkina IN , Fadeeva NA , Gubina AV , Melik-Agadzhanian NB , Poleva NI , Khomeriki SG , Chikunova BZ , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
